| Code | System | Display | Definition |
| 54 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, type 4, live, oral | |
| 55 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, type 7, live, oral | |
| 82 | http://hl7.org/fhir/sid/cvx | adenovirus vaccine, unspecified formulation | |
| 24 | http://hl7.org/fhir/sid/cvx | anthrax vaccine | |
| 19 | http://hl7.org/fhir/sid/cvx | Bacillus Calmette-Guerin vaccine | |
| 27 | http://hl7.org/fhir/sid/cvx | botulinum antitoxin | |
| 26 | http://hl7.org/fhir/sid/cvx | cholera vaccine, unspecified formulation | |
| 29 | http://hl7.org/fhir/sid/cvx | cytomegalovirus immune globulin, intravenous | |
| 56 | http://hl7.org/fhir/sid/cvx | dengue fever vaccine | |
| 12 | http://hl7.org/fhir/sid/cvx | diphtheria antitoxin | |
| 28 | http://hl7.org/fhir/sid/cvx | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
| 20 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
| 106 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | |
| 107 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | |
| 110 | http://hl7.org/fhir/sid/cvx | DTaP-hepatitis B and poliovirus vaccine | |
| 50 | http://hl7.org/fhir/sid/cvx | DTaP-Haemophilus influenzae type b conjugate vaccine | |
| 120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
| 130 | http://hl7.org/fhir/sid/cvx | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | |
| 01 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and pertussis vaccine | |
| 22 | http://hl7.org/fhir/sid/cvx | DTP-Haemophilus influenzae type b conjugate vaccine | |
| 102 | http://hl7.org/fhir/sid/cvx | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | |
| 57 | http://hl7.org/fhir/sid/cvx | hantavirus vaccine | |
| 52 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, adult dosage | |
| 83 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
| 84 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
| 31 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric dosage, unspecified formulation | |
| 85 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, unspecified formulation | |
| 104 | http://hl7.org/fhir/sid/cvx | hepatitis A and hepatitis B vaccine | |
| 30 | http://hl7.org/fhir/sid/cvx | hepatitis B immune globulin | |
| 08 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
| 42 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, adolescent/high risk infant dosage | |
| 43 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, adult dosage | |
| 44 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, dialysis patient dosage | |
| 45 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, unspecified formulation | |
| 58 | http://hl7.org/fhir/sid/cvx | hepatitis C vaccine | |
| 59 | http://hl7.org/fhir/sid/cvx | hepatitis E vaccine | |
| 60 | http://hl7.org/fhir/sid/cvx | herpes simplex virus, type 2 vaccine | |
| 46 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
| 47 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, HbOC conjugate | |
| 48 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
| 49 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
| 17 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, conjugate unspecified formulation | |
| 51 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
| 61 | http://hl7.org/fhir/sid/cvx | human immunodeficiency virus vaccine | |
| 118 | http://hl7.org/fhir/sid/cvx | human papilloma virus vaccine, bivalent | |
| 62 | http://hl7.org/fhir/sid/cvx | human papilloma virus vaccine, quadrivalent | |
| 86 | http://hl7.org/fhir/sid/cvx | immune globulin, intramuscular | |
| 87 | http://hl7.org/fhir/sid/cvx | immune globulin, intravenous | |
| 14 | http://hl7.org/fhir/sid/cvx | immune globulin, unspecified formulation | |
| 111 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, live, attenuated, for intranasal use | |
| 15 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | |
| 16 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, whole virus | |
| 88 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, unspecified formulation | |
| 123 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | |
| 10 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, inactivated | |
| 02 | http://hl7.org/fhir/sid/cvx | trivalent poliovirus vaccine, live, oral | |
| 89 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, unspecified formulation | |
| 39 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis Vaccine SC | |
| 63 | http://hl7.org/fhir/sid/cvx | Junin virus vaccine | |
| 64 | http://hl7.org/fhir/sid/cvx | leishmaniasis vaccine | |
| 65 | http://hl7.org/fhir/sid/cvx | leprosy vaccine | |
| 66 | http://hl7.org/fhir/sid/cvx | Lyme disease vaccine | |
| 03 | http://hl7.org/fhir/sid/cvx | measles, mumps and rubella virus vaccine | |
| 04 | http://hl7.org/fhir/sid/cvx | measles and rubella virus vaccine | |
| 94 | http://hl7.org/fhir/sid/cvx | measles, mumps, rubella, and varicella virus vaccine | |
| 67 | http://hl7.org/fhir/sid/cvx | malaria vaccine | |
| 05 | http://hl7.org/fhir/sid/cvx | measles virus vaccine | |
| 68 | http://hl7.org/fhir/sid/cvx | melanoma vaccine | |
| 32 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide vaccine (MPSV4) | |
| 103 | http://hl7.org/fhir/sid/cvx | meningococcal C conjugate vaccine | |
| 114 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | |
| 108 | http://hl7.org/fhir/sid/cvx | meningococcal ACWY vaccine, unspecified formulation | |
| 07 | http://hl7.org/fhir/sid/cvx | mumps virus vaccine | |
| 69 | http://hl7.org/fhir/sid/cvx | parainfluenza-3 virus vaccine | |
| 11 | http://hl7.org/fhir/sid/cvx | pertussis vaccine | |
| 23 | http://hl7.org/fhir/sid/cvx | plague vaccine | |
| 33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide vaccine, 23 valent | |
| 100 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 7 valent | |
| 109 | http://hl7.org/fhir/sid/cvx | pneumococcal vaccine, unspecified formulation | |
| 70 | http://hl7.org/fhir/sid/cvx | Q fever vaccine | |
| 18 | http://hl7.org/fhir/sid/cvx | rabies vaccine, for intramuscular injection RETIRED CODE | |
| 40 | http://hl7.org/fhir/sid/cvx | rabies vaccine, for intradermal injection | |
| 90 | http://hl7.org/fhir/sid/cvx | rabies vaccine, unspecified formulation | |
| 72 | http://hl7.org/fhir/sid/cvx | rheumatic fever vaccine | |
| 73 | http://hl7.org/fhir/sid/cvx | Rift Valley fever vaccine | |
| 34 | http://hl7.org/fhir/sid/cvx | rabies immune globulin | |
| 119 | http://hl7.org/fhir/sid/cvx | rotavirus, live, monovalent vaccine | |
| 122 | http://hl7.org/fhir/sid/cvx | rotavirus vaccine, unspecified formulation | |
| 116 | http://hl7.org/fhir/sid/cvx | rotavirus, live, pentavalent vaccine | |
| 74 | http://hl7.org/fhir/sid/cvx | rotavirus, live, tetravalent vaccine | |
| 71 | http://hl7.org/fhir/sid/cvx | respiratory syncytial virus immune globulin, intravenous | |
| 93 | http://hl7.org/fhir/sid/cvx | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
| 06 | http://hl7.org/fhir/sid/cvx | rubella virus vaccine | |
| 38 | http://hl7.org/fhir/sid/cvx | rubella and mumps virus vaccine | |
| 76 | http://hl7.org/fhir/sid/cvx | Staphylococcus bacteriophage lysate | |
| 113 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
| 09 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
| 115 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | |
| 35 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, adsorbed | |
| 112 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, unspecified formulation | |
| 77 | http://hl7.org/fhir/sid/cvx | tick-borne encephalitis vaccine | |
| 13 | http://hl7.org/fhir/sid/cvx | tetanus immune globulin | |
| 95 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; old tuberculin, multipuncture device | |
| 96 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; purified protein derivative solution, intradermal | |
| 97 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; purified protein derivative, multipuncture device | |
| 98 | http://hl7.org/fhir/sid/cvx | tuberculin skin test; unspecified formulation | |
| 78 | http://hl7.org/fhir/sid/cvx | tularemia vaccine | |
| 91 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, unspecified formulation | |
| 25 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, live, oral | |
| 41 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, parenteral, other than acetone-killed, dried | |
| 53 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
| 101 | http://hl7.org/fhir/sid/cvx | typhoid Vi capsular polysaccharide vaccine | |
| 75 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) vaccine | |
| 105 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) vaccine, diluted | |
| 79 | http://hl7.org/fhir/sid/cvx | vaccinia immune globulin | |
| 21 | http://hl7.org/fhir/sid/cvx | varicella virus vaccine | |
| 81 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis, inactivated | |
| 80 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis, live, attenuated | |
| 92 | http://hl7.org/fhir/sid/cvx | Venezuelan equine encephalitis vaccine, unspecified formulation | |
| 36 | http://hl7.org/fhir/sid/cvx | varicella zoster immune globulin | |
| 117 | http://hl7.org/fhir/sid/cvx | varicella zoster immune globulin (Investigational New Drug) | |
| 37 | http://hl7.org/fhir/sid/cvx | yellow fever vaccine | |
| 121 | http://hl7.org/fhir/sid/cvx | zoster vaccine, live | |
| 998 | http://hl7.org/fhir/sid/cvx | no vaccine administered | |
| 999 | http://hl7.org/fhir/sid/cvx | unknown vaccine or immune globulin | |
| 99 | http://hl7.org/fhir/sid/cvx | RESERVED - do not use | |
| 133 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 13 valent | |
| 134 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis vaccine for intramuscular administration | |
| 137 | http://hl7.org/fhir/sid/cvx | HPV, unspecified formulation | |
| 136 | http://hl7.org/fhir/sid/cvx | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | |
| 135 | http://hl7.org/fhir/sid/cvx | influenza, high dose seasonal, preservative-free | |
| 131 | http://hl7.org/fhir/sid/cvx | Historical record of a typhus vaccination | |
| 132 | http://hl7.org/fhir/sid/cvx | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. | |
| 128 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, all formulations | |
| 125 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, live virus for nasal administration | |
| 126 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, preservative-free, injectable | |
| 127 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, injectable | |
| 138 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, not adsorbed, for adult use | |
| 139 | http://hl7.org/fhir/sid/cvx | Td(adult) unspecified formulation | |
| 140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free | |
| 129 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis vaccine, unspecified formulation | |
| 141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable | |
| 142 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, not adsorbed | |
| 143 | http://hl7.org/fhir/sid/cvx | Adenovirus, type 4 and type 7, live, oral | |
| 144 | http://hl7.org/fhir/sid/cvx | seasonal influenza, intradermal, preservative free | |
| 145 | http://hl7.org/fhir/sid/cvx | respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular | |
| 146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. | |
| 147 | http://hl7.org/fhir/sid/cvx | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | |
| 148 | http://hl7.org/fhir/sid/cvx | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | |
| 149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent | |
| 150 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, quadrivalent, preservative free | |
| 151 | http://hl7.org/fhir/sid/cvx | influenza nasal, unspecified formulation | |
| 152 | http://hl7.org/fhir/sid/cvx | Pneumococcal Conjugate, unspecified formulation | |
| 153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free | |
| 154 | http://hl7.org/fhir/sid/cvx | Hepatitis A immune globulin | |
| 155 | http://hl7.org/fhir/sid/cvx | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free | |
| 156 | http://hl7.org/fhir/sid/cvx | Rho(D) Immune globulin- IV or IM | |
| 157 | http://hl7.org/fhir/sid/cvx | Rho(D) Immune globulin - IM | |
| 158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, contains preservative | |
| 159 | http://hl7.org/fhir/sid/cvx | Rho(D) Unspecified formulation | |
| 160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | |
| 801 | http://hl7.org/fhir/sid/cvx | AS03 Adjuvant | |
| 161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric | |
| 162 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, fully recombinant | |
| 163 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, recombinant, OMV, adjuvanted | |
| 164 | http://hl7.org/fhir/sid/cvx | meningococcal B, unspecified formulation | |
| 165 | http://hl7.org/fhir/sid/cvx | Human Papillomavirus 9-valent vaccine | |
| 166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free, injectable | |
| 167 | http://hl7.org/fhir/sid/cvx | meningococcal vaccine of unknown formulation and unknown serogroups | |
| 168 | http://hl7.org/fhir/sid/cvx | Seasonal trivalent influenza vaccine, adjuvanted, preservative free | |
| 169 | http://hl7.org/fhir/sid/cvx | Hep A, live attenuated-IM | |
| 170 | http://hl7.org/fhir/sid/cvx | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
| 171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent | |
| 172 | http://hl7.org/fhir/sid/cvx | cholera, WC-rBS | |
| 173 | http://hl7.org/fhir/sid/cvx | cholera, BivWC | |
| 174 | http://hl7.org/fhir/sid/cvx | cholera, live attenuated | |
| 175 | http://hl7.org/fhir/sid/cvx | Human Rabies vaccine from human diploid cell culture | |
| 176 | http://hl7.org/fhir/sid/cvx | Human rabies vaccine from Chicken fibroblast culture | |
| 177 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 10 valent | |
| 178 | http://hl7.org/fhir/sid/cvx | Non-US bivalent oral polio vaccine (types 1 and 3) | |
| 179 | http://hl7.org/fhir/sid/cvx | Non-US monovalent oral polio vaccine, unspecified formulation | |
| 180 | http://hl7.org/fhir/sid/cvx | tetanus immune globulin | |
| 181 | http://hl7.org/fhir/sid/cvx | anthrax immune globulin | |
| 182 | http://hl7.org/fhir/sid/cvx | Oral Polio Vaccine, Unspecified formulation | |
| 183 | http://hl7.org/fhir/sid/cvx | Yellow fever vaccine alternative formulation | |
| 184 | http://hl7.org/fhir/sid/cvx | Yellow fever vaccine, unspecified formulation | |
| 185 | http://hl7.org/fhir/sid/cvx | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free | |
| 186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative | |
| 187 | http://hl7.org/fhir/sid/cvx | zoster vaccine recombinant | |
| 188 | http://hl7.org/fhir/sid/cvx | zoster vaccine, unspecified formulation | |
| 189 | http://hl7.org/fhir/sid/cvx | Hepatitis B vaccine (recombinant), CpG adjuvanted | |
| 190 | http://hl7.org/fhir/sid/cvx | Typhoid conjugate vaccine (non-US) | |
| 191 | http://hl7.org/fhir/sid/cvx | meningococcal A polysaccharide vaccine (non-US) | |
| 192 | http://hl7.org/fhir/sid/cvx | meningococcal AC polysaccharide vaccine (non-US) | |
| 193 | http://hl7.org/fhir/sid/cvx | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) | |
| 194 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, unspecified formulation | |
| 195 | http://hl7.org/fhir/sid/cvx | Diphtheria, Tetanus, Poliomyelitis adsorbed | |
| 196 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified | |
| 197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free | |
| 200 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free | |
| 201 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative | |
| 202 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative | |
| 198 | http://hl7.org/fhir/sid/cvx | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) | |
| 203 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free | |
| 205 | http://hl7.org/fhir/sid/cvx | influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free | |
| 206 | http://hl7.org/fhir/sid/cvx | smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile) | |
| 207 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose | |
| 208 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose | |
| 213 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | |
| 210 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | |
| 212 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 ml | |
| 204 | http://hl7.org/fhir/sid/cvx | Ebola Zaire vaccine, live, recombinant, 1mL dose | |
| 214 | http://hl7.org/fhir/sid/cvx | Ebola, unspecified | |
| 211 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose | |
| AGRPAL | urn:oid:1.2.36.1.2001.1005.17 | Agrippal | |
| AVAXM | urn:oid:1.2.36.1.2001.1005.17 | Avaxim | |
| BCG | urn:oid:1.2.36.1.2001.1005.17 | BCG | |
| CDT | urn:oid:1.2.36.1.2001.1005.17 | CDT | |
| CMX | urn:oid:1.2.36.1.2001.1005.17 | COMVAX | |
| DTP | urn:oid:1.2.36.1.2001.1005.17 | Triple Antigen | |
| DTPA | urn:oid:1.2.36.1.2001.1005.17 | DTPa | |
| ENGP | urn:oid:1.2.36.1.2001.1005.17 | Engerix B | |
| FLRIX | urn:oid:1.2.36.1.2001.1005.17 | Fluarix | |
| FLUVAX | urn:oid:1.2.36.1.2001.1005.17 | Fluvax | |
| FLVRN | urn:oid:1.2.36.1.2001.1005.17 | Fluvirin | |
| FVXJNR | urn:oid:1.2.36.1.2001.1005.17 | Fluvax Junior | |
| GNDIP | urn:oid:1.2.36.1.2001.1005.17 | Diphtheria | |
| GNFLU | urn:oid:1.2.36.1.2001.1005.17 | Influenza | |
| GNHEP | urn:oid:1.2.36.1.2001.1005.17 | Hepatitis B | |
| GNHIB | urn:oid:1.2.36.1.2001.1005.17 | HIB | |
| GNHPA | urn:oid:1.2.36.1.2001.1005.17 | Hepatitis A | |
| GNJEN | urn:oid:1.2.36.1.2001.1005.17 | Japanese Encephalitis | |
| GNMEA | urn:oid:1.2.36.1.2001.1005.17 | Measles | |
| GNMEN | urn:oid:1.2.36.1.2001.1005.17 | Meningococcal C | |
| GNMUM | urn:oid:1.2.36.1.2001.1005.17 | Mumps | |
| GNPNE | urn:oid:1.2.36.1.2001.1005.17 | Pneumococcal | |
| GNPOL | urn:oid:1.2.36.1.2001.1005.17 | Polio | |
| GNROX | urn:oid:1.2.36.1.2001.1005.17 | Rotavirus | |
| GNRUB | urn:oid:1.2.36.1.2001.1005.17 | Rubella | |
| GNTET | urn:oid:1.2.36.1.2001.1005.17 | Tetanus | |
| GNVAR | urn:oid:1.2.36.1.2001.1005.17 | Varicella | |
| HATWNJ | urn:oid:1.2.36.1.2001.1005.17 | Twinrix Junior | |
| HAVAQ | urn:oid:1.2.36.1.2001.1005.17 | Vaqta Paed/Adol | |
| HAVJ | urn:oid:1.2.36.1.2001.1005.17 | Havrix Junior | |
| HBOC | urn:oid:1.2.36.1.2001.1005.17 | HibTITER | |
| HBV | urn:oid:1.2.36.1.2001.1005.17 | HBV | |
| HBVP | urn:oid:1.2.36.1.2001.1005.17 | HBVAX II | |
| HBX | urn:oid:1.2.36.1.2001.1005.17 | Hiberix | |
| IFHX | urn:oid:1.2.36.1.2001.1005.17 | Infanrix Hexa | |
| IFIP | urn:oid:1.2.36.1.2001.1005.17 | Infanrix-IPV | |
| IFPA | urn:oid:1.2.36.1.2001.1005.17 | Infanrix Penta | |
| IFX | urn:oid:1.2.36.1.2001.1005.17 | Infanrix | |
| IFXB | urn:oid:1.2.36.1.2001.1005.17 | InfanrixHepB | |
| INFLUV | urn:oid:1.2.36.1.2001.1005.17 | Influvac | |
| IPV | urn:oid:1.2.36.1.2001.1005.17 | IPOL | |
| JEVAX | urn:oid:1.2.36.1.2001.1005.17 | JE-VAX | |
| MENJUG | urn:oid:1.2.36.1.2001.1005.17 | Menjugate | |
| MENTEC | urn:oid:1.2.36.1.2001.1005.17 | Meningitec | |
| MENUME | urn:oid:1.2.36.1.2001.1005.17 | Menomune | |
| MENVAX | urn:oid:1.2.36.1.2001.1005.17 | Mencevax ACWY | |
| MMR | urn:oid:1.2.36.1.2001.1005.17 | MMR | |
| MMRCSL | urn:oid:1.2.36.1.2001.1005.17 | MMR II | |
| MMRSKB | urn:oid:1.2.36.1.2001.1005.17 | Priorix | |
| MNTRX | urn:oid:1.2.36.1.2001.1005.17 | Menitorix | |
| NEISVC | urn:oid:1.2.36.1.2001.1005.17 | NeisVac-C | |
| OPV | urn:oid:1.2.36.1.2001.1005.17 | Polio | |
| P | urn:oid:1.2.36.1.2001.1005.17 | Pertussis | |
| PANVAX | urn:oid:1.2.36.1.2001.1005.17 | Panvax | |
| PDCL | urn:oid:1.2.36.1.2001.1005.17 | Pediacel | |
| PLCL | urn:oid:1.2.36.1.2001.1005.17 | Poliacel | |
| PNEUMO | urn:oid:1.2.36.1.2001.1005.17 | Pneumovax | |
| PRPD | urn:oid:1.2.36.1.2001.1005.17 | ProHIBit | |
| PROQAD | urn:oid:1.2.36.1.2001.1005.17 | ProQuad | |
| PRPOMP | urn:oid:1.2.36.1.2001.1005.17 | PedvaxHIB | |
| PRPT | urn:oid:1.2.36.1.2001.1005.17 | ActHIB | |
| PRVNR | urn:oid:1.2.36.1.2001.1005.17 | Prevenar 7 | |
| PRVTH | urn:oid:1.2.36.1.2001.1005.17 | Prevenar 13 | |
| PRXTEX | urn:oid:1.2.36.1.2001.1005.17 | Priorix-Tetra | |
| QDCL | urn:oid:1.2.36.1.2001.1005.17 | Quadracel | |
| ROTRIX | urn:oid:1.2.36.1.2001.1005.17 | Rotarix | |
| ROTTEQ | urn:oid:1.2.36.1.2001.1005.17 | Rotateq | |
| SYNFLX | urn:oid:1.2.36.1.2001.1005.17 | Synflorix | |
| TCL | urn:oid:1.2.36.1.2001.1005.17 | Tripacel | |
| VAXGRP | urn:oid:1.2.36.1.2001.1005.17 | Vaxigrip | |
| VGRJNR | urn:oid:1.2.36.1.2001.1005.17 | Vaxigrip Junior | |
| VLRIX | urn:oid:1.2.36.1.2001.1005.17 | Varilrix | |
| VRVAX | urn:oid:1.2.36.1.2001.1005.17 | Varivax | |
| Code | English (English, en) |
| 54 | adenovirus, type 4 |
| 55 | adenovirus, type 7 |
| 82 | adenovirus, unspecified formulation |
| 24 | anthrax |
| 19 | BCG |
| 27 | |
| 26 | cholera, unspecified formulation |
| 29 | CMVIG |
| 56 | dengue fever |
| 12 | |
| 28 | DT (pediatric) |
| 20 | DTaP |
| 106 | DTaP, 5 pertussis antigens |
| 107 | DTaP, unspecified formulation |
| 110 | DTaP-Hep B-IPV |
| 50 | DTaP-Hib |
| 120 | DTaP-Hib-IPV |
| 130 | DTaP-IPV |
| 01 | DTP |
| 22 | DTP-Hib |
| 102 | DTP-Hib-Hep B |
| 57 | hantavirus |
| 52 | Hep A, adult |
| 83 | Hep A, ped/adol, 2 dose |
| 84 | Hep A, ped/adol, 3 dose |
| 31 | Hep A, pediatric, unspecified formulation |
| 85 | Hep A, unspecified formulation |
| 104 | Hep A-Hep B |
| 30 | HBIG |
| 08 | Hep B, adolescent or pediatric |
| 42 | Hep B, adolescent/high risk infant |
| 43 | Hep B, adult |
| 44 | Hep B, dialysis |
| 45 | Hep B, unspecified formulation |
| 58 | Hep C |
| 59 | Hep E |
| 60 | herpes simplex 2 |
| 46 | Hib (PRP-D) |
| 47 | Hib (HbOC) |
| 48 | Hib (PRP-T) |
| 49 | Hib (PRP-OMP) |
| 17 | Hib, unspecified formulation |
| 51 | Hib-Hep B |
| 61 | HIV |
| 118 | HPV, bivalent |
| 62 | HPV, quadrivalent |
| 86 | IG |
| 87 | IGIV |
| 14 | IG, unspecified formulation |
| 111 | influenza, live, intranasal |
| 15 | influenza, split (incl. purified surface antigen) |
| 16 | influenza, whole |
| 88 | influenza, unspecified formulation |
| 123 | influenza, H5N1-1203 |
| 10 | IPV |
| 02 | OPV |
| 89 | polio, unspecified formulation |
| 39 | Japanese encephalitis SC |
| 63 | Junin virus |
| 64 | leishmaniasis |
| 65 | leprosy |
| 66 | Lyme disease |
| 03 | MMR |
| 04 | M/R |
| 94 | MMRV |
| 67 | malaria |
| 05 | measles |
| 68 | melanoma |
| 32 | meningococcal MPSV4 |
| 103 | meningococcal C conjugate |
| 114 | meningococcal MCV4P |
| 108 | meningococcal ACWY, unspecified formulation |
| 07 | mumps |
| 69 | parainfluenza-3 |
| 11 | pertussis |
| 23 | plague |
| 33 | pneumococcal polysaccharide PPV23 |
| 100 | pneumococcal conjugate PCV 7 |
| 109 | pneumococcal, unspecified formulation |
| 70 | Q fever |
| 18 | rabies, intramuscular injection |
| 40 | rabies, intradermal injection |
| 90 | rabies, unspecified formulation |
| 72 | rheumatic fever |
| 73 | Rift Valley fever |
| 34 | RIG |
| 119 | rotavirus, monovalent |
| 122 | rotavirus, unspecified formulation |
| 116 | rotavirus, pentavalent |
| 74 | rotavirus, tetravalent |
| 71 | RSV-IGIV |
| 93 | RSV-MAb |
| 06 | rubella |
| 38 | rubella/mumps |
| 76 | Staphylococcus bacterio lysate |
| 113 | Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
| 09 | Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed |
| 115 | Tdap |
| 35 | |
| 112 | |
| 77 | tick-borne encephalitis |
| 13 | TIG |
| 95 | TST-OT tine test |
| 96 | TST-PPD intradermal |
| 97 | TST-PPD tine test |
| 98 | TST, unspecified formulation |
| 78 | |
| 91 | typhoid, unspecified formulation |
| 25 | typhoid, oral |
| 41 | typhoid, parenteral |
| 53 | typhoid, parenteral, AKD (U.S. military) |
| 101 | typhoid, ViCPs |
| 75 | vaccinia (smallpox) |
| 105 | vaccinia (smallpox) diluted |
| 79 | |
| 21 | varicella |
| 81 | VEE, inactivated |
| 80 | VEE, live |
| 92 | VEE, unspecified formulation |
| 36 | VZIG |
| 117 | VZIG (IND) |
| 37 | yellow fever |
| 121 | zoster live |
| 998 | |
| 999 | unknown |
| 99 | |
| 133 | Pneumococcal conjugate PCV 13 |
| 134 | Japanese Encephalitis IM |
| 137 | |
| 136 | Meningococcal MCV4O |
| 135 | Influenza, high dose seasonal |
| 131 | typhus, historical |
| 132 | DTaP-IPV-HIB-HEP B, historical |
| 128 | Novel Influenza-H1N1-09, all formulations |
| 125 | Novel Influenza-H1N1-09, nasal |
| 126 | Novel influenza-H1N1-09, preservative-free |
| 127 | Novel influenza-H1N1-09 |
| 138 | Td (adult) |
| 139 | |
| 140 | |
| 129 | Japanese Encephalitis, unspecified formulation |
| 141 | |
| 142 | |
| 143 | Adenovirus types 4 and 7 |
| 144 | influenza, seasonal, intradermal, preservative free |
| 145 | RSV-MAb (new) |
| 146 | DTaP,IPV,Hib,HepB |
| 147 | meningococcal MCV4, unspecified formulation |
| 148 | Meningococcal C/Y-HIB PRP |
| 149 | |
| 150 | influenza, injectable, quadrivalent, preservative free |
| 151 | |
| 152 | |
| 153 | Influenza, injectable, MDCK, preservative free |
| 154 | Hep A, IG |
| 155 | influenza, recombinant, injectable, preservative free |
| 156 | Rho(D)-IG |
| 157 | Rho(D) -IG IM |
| 158 | influenza, injectable, quadrivalent |
| 159 | Rho(D) - Unspecified formulation |
| 160 | Influenza A monovalent (H5N1), ADJUVANTED-2013 |
| 801 | |
| 161 | |
| 162 | meningococcal B, recombinant |
| 163 | meningococcal B, OMV |
| 164 | meningococcal B, unspecified |
| 165 | HPV9 |
| 166 | influenza, intradermal, quadrivalent, preservative free |
| 167 | meningococcal, unknown serogroups |
| 168 | influenza, trivalent, adjuvanted |
| 169 | Hep A, live attenuated |
| 170 | DTAP/IPV/HIB - non-US |
| 171 | Influenza, injectable, MDCK, preservative free, quadrivalent |
| 172 | |
| 173 | |
| 174 | |
| 175 | Rabies - IM Diploid cell culture |
| 176 | Rabies - IM fibroblast culture |
| 177 | PCV10 |
| 178 | OPV bivalent |
| 179 | OPV ,monovalent, unspecified |
| 180 | |
| 181 | |
| 182 | OPV, Unspecified |
| 183 | Yellow fever vaccine - alt |
| 184 | Yellow fever, unspecified formulation |
| 185 | influenza, recombinant, quadrivalent,injectable, preservative free |
| 186 | Influenza, injectable, MDCK, quadrivalent, preservative |
| 187 | zoster recombinant |
| 188 | zoster, unspecified formulation |
| 189 | HepB-CpG |
| 190 | Typhoid conjugate vaccine (TCV) |
| 191 | meningococcal A polysaccharide (non-US) |
| 192 | meningococcal AC polysaccharide (non-US) |
| 193 | Hep A-Hep B, pediatric/adolescent |
| 194 | Influenza, Southern Hemisphere |
| 195 | DT, IPV adsorbed |
| 196 | Td, adsorbed, preservative free, adult use, Lf unspecified |
| 197 | influenza, high-dose, quadrivalent |
| 200 | influenza, Southern Hemisphere, pediatric, preservative free |
| 201 | influenza, Southern Hemisphere, preservative free |
| 202 | influenza, Southern Hemisphere, quadrivalent, with preservative |
| 198 | DTP-hepB-Hib Pentavalent Non-US |
| 203 | meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate |
| 205 | Influenza vaccine, quadrivalent, adjuvanted |
| 206 | Smallpox monkeypox vaccine (National Stockpile) |
| 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose |
| 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
| 213 | |
| 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
| 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
| 204 | |
| 214 | |
| 211 | COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |
| AGRPAL | |
| AVAXM | |
| BCG | |
| CDT | |
| CMX | |
| DTP | |
| DTPA | |
| ENGP | |
| FLRIX | |
| FLUVAX | |
| FLVRN | |
| FVXJNR | |
| GNDIP | |
| GNFLU | |
| GNHEP | |
| GNHIB | |
| GNHPA | |
| GNJEN | |
| GNMEA | |
| GNMEN | |
| GNMUM | |
| GNPNE | |
| GNPOL | |
| GNROX | |
| GNRUB | |
| GNTET | |
| GNVAR | |
| HATWNJ | |
| HAVAQ | |
| HAVJ | |
| HBOC | |
| HBV | |
| HBVP | |
| HBX | |
| IFHX | |
| IFIP | |
| IFPA | |
| IFX | |
| IFXB | |
| INFLUV | |
| IPV | |
| JEVAX | |
| MENJUG | |
| MENTEC | |
| MENUME | |
| MENVAX | |
| MMR | |
| MMRCSL | |
| MMRSKB | |
| MNTRX | |
| NEISVC | |
| OPV | |
| P | |
| PANVAX | |
| PDCL | |
| PLCL | |
| PNEUMO | |
| PRPD | |
| PROQAD | |
| PRPOMP | |
| PRPT | |
| PRVNR | |
| PRVTH | |
| PRXTEX | |
| QDCL | |
| ROTRIX | |
| ROTTEQ | |
| SYNFLX | |
| TCL | |
| VAXGRP | |
| VGRJNR | |
| VLRIX | |
| VRVAX | |